19
Hetero Drugs, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TADALAFIL, with a corresponding application number 209908.
Regulatory Information RX
With a dosage strength 10MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2019-03-26
Therapeutic Equivalence (TE) Code AB1
18
Hetero Drugs, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TADALAFIL, with a corresponding application number 209908.
Regulatory Information RX
With a dosage strength 2.5MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2019-03-26
Therapeutic Equivalence (TE) Code AB1
17
Hetero Drugs, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TADALAFIL, with a corresponding application number 209908.
Regulatory Information RX
With a dosage strength 20MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2019-03-26
Therapeutic Equivalence (TE) Code AB1
16
Hetero Drugs, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TADALAFIL, with a corresponding application number 209908.
Regulatory Information RX
With a dosage strength 5MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2019-03-26
Therapeutic Equivalence (TE) Code AB1